Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire-Reference-Cited by-同舟云学术

Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire

Published:2017-09 Issue:9 Volume:28 Page:2191-2198
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Le Bourgeois A.,Labopin M.,Blaise D.,Ceballos P.,Vigouroux S.,Peffault de Latour R.,Marçais A.,Bulabois C.E.,Bay J.O.,Chantepie S.,Deconinck E.,Daguindau E.,Contentin N.,Yakoub-Agha I.,Cornillon J.,Mercier M.,Turlure P.,Charbonnier A.,Rorhlich P.S.,N’Guyen S.,Maillard N.,Marchand T.,Mohty M.,Chevallier P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/9/2191/19709815/mdx274.pdf

Reference42 articles.

1. Advancement in high dose therapy and autologous stem cell rescue in lymphoma;Isidori;World J Stem Cells,2015

2. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation;Gkotzamanidou;Crit Rev Oncol Hematol,2014

3. Recent progress: hematopoietic cell transplant for diffuse large B-cell lymphoma;Faroog;Leuk Lymphoma,2015

4. The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma;Robinson;Leukemia,2015

5. Follicular lymphoma: evolving therapeutic strategies;Kahl;Blood,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT);Bone Marrow Transplantation;2024-09-13

2. Reduced‐intensity conditioning with fludarabine/busulfan versus fludarabine/low‐dose melphalan in patients with non‐Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation;British Journal of Haematology;2024-07-24

3. Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation;Transplantation and Cellular Therapy;2024-01

4. Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation;Annals of Hematology;2023-01-12

5. Stem Cell Transplant for B Cell Non-Hodgkin Lymphoma;Basics of Hematopoietic Stem Cell Transplant;2023